Periodic Reporting for period 1 - SusIsocyanide (A New Light on Isocyanide Synthesis)
Reporting period: 2023-01-01 to 2024-12-31
The SusIsocyanide project addresses this pressing need by pioneering new methodologies for the scalable and eco-friendly synthesis of isocyanides. Central to this effort is the use of photoflow reactors, which harness visible light as a renewable energy source. By integrating bio-based scaffolds, the project aims to achieve enhanced efficiency and sustainability in isocyanide production.
The project's outcomes are expected to have a transformative impact on both scientific innovation and societal needs. By utilizing non-toxic chemicals and renewable resources, SusIsocyanide seeks to minimize environmental impact, enable cost-effective large-scale production, and enhance the accessibility of isocyanides. These advances will support their broader application across industries, offering significant benefits in healthcare, materials development, and beyond.
A breakthrough discovery emerged during this work: aromatic isocyanides were found to form aggregates under light irradiation, enabling absorption in the visible region. These aggregates undergo charge transfer, generating imidoyl radical anions, which can facilitate single electron transfer or hydrogen atom transfer reactions. This mechanism opens pathways to a diverse array of valuable scaffolds for medicinal and polymer chemistry.
In addition, in collaboration with the polymer research group at AMIBM, we demonstrated a novel application of isocyanides in the synthesis of polyester-amides. This work resulted in the development of sequence-controlled polyester-amides, promising materials with potential as environmentally friendly washing additives.
Additionally, the project introduced an efficient and eco-friendly method for synthesizing valuable chemical scaffolds, including spiroindolenines, thioformamides, and amidines, thereby making previously challenging compounds more accessible. These advancements open avenues for further research and broader applications across multiple fields. Notably, amidine and spiroindolenine scaffolds will be screened for biological activity in collaboration with a medicinal chemistry research group.